| 持有 复星医药(600196)的基金 |
| 报告期：2022-09-30 |
| 序号 |
基金代码 |
基金简称 |
持仓市值(元) |
持仓数量(股) |
占基金净值比例(%) |
| 1 | 161726 | 招商国证生物医药指数分级 | 601,890,231.10 | 20,483,039.00 | 4.47 |
| 2 | 159992 | 银华中证创新药产业ETF | 167,888,828.20 | 5,679,595.00 | 3.86 |
| 3 | 501009 | 汇添富中证生物科技指数(LOF)A | 121,709,072.92 | 4,117,357.00 | 3.92 |
| 4 | 501010 | 汇添富中证生物科技指数(LOF)C | 121,709,072.92 | 4,117,357.00 | 3.92 |
| 5 | 001257 | 兴业收益增强债券A | 110,258,800.00 | 3,730,000.00 | 1.39 |
| 6 | 001258 | 兴业收益增强债券C | 110,258,800.00 | 3,730,000.00 | 1.39 |
| 7 | 515120 | 广发中证创新药产业ETF | 64,833,800.20 | 2,193,295.00 | 3.90 |
| 8 | 005985 | 兴业聚华混合C | 59,415,600.00 | 2,010,000.00 | 1.98 |
| 9 | 005984 | 兴业聚华混合A | 59,415,600.00 | 2,010,000.00 | 1.98 |
| 10 | 000014 | 华夏聚利债券 | 20,014,265.70 | 714,285.00 | 0.62 |
| 11 | 515960 | 嘉实医药健康100成长估值ETF | 7,901,388.00 | 267,300.00 | 2.64 |
| 12 | 512120 | 华安中证细分医药ETF | 7,879,809.20 | 266,570.00 | 2.69 |
| 13 | 165519 | 信诚中证800医药指数分级 | 7,225,882.88 | 244,448.00 | 2.63 |
| 14 | 510660 | 华夏医药ETF | 3,930,888.80 | 132,980.00 | 4.08 |
| 15 | 002316 | 创金合信中证500增强C | 3,148,140.00 | 106,500.00 | 0.66 |
| 16 | 002311 | 创金合信中证500增强A | 3,148,140.00 | 106,500.00 | 0.66 |
| 17 | 005717 | 兴业机遇债券A | 2,542,160.00 | 86,000.00 | 1.86 |
| 18 | 008222 | 兴业机遇债券C | 2,542,160.00 | 86,000.00 | 1.86 |
